
Breast cancer (BC) poses a significant global health threat, with disulfidptosis, a cell death type, potentially influencing tumour cell demise. The study examined the impact of disulfidptosis-related genes (DRGs) on BC prognosis and immune infiltration. Analyzing TCGA-BRCA data, two subtypes emerged: cluster1, associated with favourable survival, exhibited lower immune-related cell infiltration and potential benefits from immune checkpoint inhibitors. Cluster2, identified as responsive to certain small molecules, displayed enrichment in specific signaling pathways. The classification aids in predicting BC patient outcomes and refining clinical management and treatment approaches.
Like
Save
Share